AcadeMab Biomedical Pipeline
| Drug | Indication | Phase |
|---|
| AM-928 | EpCAM‑positive solid tumors (colorectal, nasopharyngeal, esophageal) | Phase 1 |
| AM-DV-01 | Dengue fever (ADE prevention) | Preclinical |
| AM-168 | HER3‑driven resistance in breast and lung cancer | Preclinical |
| SB-001 | Severe COVID‑19 | Preclinical |